Rebecca Stadel, Ph.D.
Affiliations: | 2008 | Albany Medical College of Union University |
Area:
Pain researchGoogle:
"Rebecca Stadel"Mean distance: 30533.1
Parents
Sign in to add mentorLindsay B. Hough | grad student | 2008 | Albany Medical College of Union University | |
(Characterization, purification, and significance of cimetidine-binding proteins.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Stadel R, Ahn KH, Kendall DA. (2011) The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. Journal of Neurochemistry. 117: 1-18 |
Stadel R, Carpenter AB, Nalwalk JW, et al. (2010) Inhibition of brain [(3)H]cimetidine binding by improgan-like antinociceptive drugs. European Journal of Pharmacology. 632: 33-8 |
Stadel R, Yang J, Nalwalk JW, et al. (2008) High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 614-21 |
Hough LB, Nalwalk JW, Phillips JG, et al. (2007) CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist. Neuropharmacology. 52: 1244-55 |
Cannon KE, Nalwalk JW, Stadel R, et al. (2003) Activation of spinal histamine H3 receptors inhibits mechanical nociception. European Journal of Pharmacology. 470: 139-47 |
Hough LB, Nalwalk JW, Stadel R, et al. (2002) Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors. The Journal of Pharmacology and Experimental Therapeutics. 303: 314-22 |